DRUGS IN THE PIPELINE FOR
HIDRADENITIS SUPPURATIVA
Drugs in the pipeline for hidradenitis suppurativa are being developed and tested, but haven’t been approved by the U.S. Food and Drug Administration (FDA). Drugs must be tested in three phases of clinical trials before the FDA decides whether to approve them.
We will report drugs being developed for hidradenitis suppurativa, learn about the differences between clinical trial phases, and see available clinical trial results.